Early tracing of children lost to follow-up from antiretroviral treatment: True outcomes and future risks

Journal of Acquired Immune Deficiency Syndromes

Volumn 70, Issue 5, 2015, Pages e160-e167

  Ardura Garcia, Cristina ^a   Feldacker, Caryl ^a,b   Tweya, Hannock ^b,c   Chaweza, Thom ^b   Kalulu, Mike ^b   Phiri, Sam ^b   Wang, Duolao ^a   Weigel, Ralf ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LIGHTHOUSE TRUST   (Malawi)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

Antiretroviral therapy; Loss to follow up; Malawi; Patient tracing; Pediatric ART; Sub Saharan Africa

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE;

ARTICLE; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTACT EXAMINATION; CONTROLLED STUDY; DEATH; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; DRUG SAFETY; DRUG USE; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; MAJOR CLINICAL STUDY; MALAWI; MALE; MEDICAL INFORMATION SYSTEM; MEDICATION COMPLIANCE; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT TRANSPORT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCHOOL CHILD; TREATMENT OUTCOME; HIV INFECTIONS; PROPORTIONAL HAZARDS MODEL;

ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MALE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84947751944     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000772     Document Type: Article

References (37)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. Available at: http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS- Global-Report-2013-en.pdf. Accessed on March 3, 2014.
2. Leroy V, Malateste K, Rabie H, et al. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr. 2013;62:208-219.
3. Braitstein P, Katshcke A, ChangYu S, et al. Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya. Trop Med Int Health. 2010;15: 833-841.
4. Fatti G, Bock P, Grimwood A, et al. Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study. J Int AIDS Soc. 2010;13:46.
5. Sengayi M, Dwane N, Marinda E, et al. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa. Glob Health Action. 2013;6:19248.
6. Braitstein P, Songok J, Vreeman RC, et al. Wamepotea (they have become lost): outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in Western Kenya. J Acquir Immune Defic Syndr. 2011;57:e40-e46.
7. McGuire M, Munyenyembe T, Szumilin E, et al. Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health. 2010;15:55-62.
8. Geng EH, Bangsberg DR, Musinguzi N, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr. 2010;53:405-411.
9. Tenthani L, Haas AD, Tweya H, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ("Option B+") in Malawi. AIDS. 2014;28:589-598.
10. Ware NC, Wyatt MA, Geng EH, et al. Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLoS Med. 2013;10:e1001369; discussion e1001369.
11. WHO. IV drug resistance early warning indicators. World Health Organization indicators to monitor HIV drug resistance prevention at antiretroviral treatment sites. 2010. Available at: http://www.unaids.org.br/biblioteca/links/OPAS-OPS/OPAS%2014.pdf. Accessed on March 3, 2014.
12. WHO. Meeting Report on Assessment of WHO HIV Drug Resistance Early Warning Indicators. Report of the Early Warning Indicator Advisory Panel Meeting. 2012. Available at: http://apps.who.int/iris/bitstream/10665/75186/1/9789241503945-eng.pdf?ua=1. Accessed on March 3, 2014.
13. Lowenthal ED, Bakeera-Kitaka S, Marukutira T, et al. Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges. Lancet Infect Dis. 2014;14:627-639.
14. Luebbert J, Tweya H, Phiri S, et al. Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in Lilongwe, Malawi. Clin Infect Dis. 2012;55:441-448.
15. Nakiwogga-Muwanga A, Musaazi J, Katabira E, et al. Patients who return to care after tracking remain at high risk of attrition: experience from a large HIV clinic, Uganda. Int JSTD AIDS. 2015;26:42-47.
16. Tweya H, Gareta D, Chagwera F, et al. Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the "Back-to-Care" project in Lilongwe, Malawi. Trop Med Int Health. 2010;15:82-89.
17. Tweya H, Feldacker C, Estill J, et al. Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi. PLoS One. 2013;8:e75761.
18. Ministry of Health Malawi. Treatment of AIDS. Guidelines for the Use of Antiretroviral Therapy in Malawi. 2nd ed. Lilongwe, Malawi: Ministry of Health of Malawi; 2006.
19. Ministry of Health of Malawi. Treatment of AIDS. Guidelines for the Use of Antiretroviral Therapy in Malawi. 3rd ed. Lilongwe, Malawi: Ministry of Health of Malawi; 2008.
20. Douglas GP, Gadabu OJ, Joukes S, et al. Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med. 2010;7:e1000319.
21. Ministry of Health of Malawi. Clinical Management of HIV in Children and Adults. Malawi Integrated Guidelines for Providing HIV Services. 1st ed. Lilongwe, Malawi: Ministry of Health of Malawi; 2011.
22. WHO. WHO Case Definitions of HIV for Surveillance and Revised Clinical staging and Immunological Classification ofHIV-Related Disease in Adults and Children. Geneva, Switzerland: World Health Organization; 2007. Available at: http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf. Accessed on March 3, 2014.
23. WHO. WHO AnthroII PC. Version 3. 2.2. 2007. Available at: http://www. who.int/childgrowth/software/en/. Accessed on March 3, 2014.
24. WHO. Reference 2007 SPSS Macro Package. 2007. Available at: http://www.who.int/growthref/tools/en/. Accessed on March 3, 2014.
25. Google Inc. Google Earth Software. Version 5.1.3533.1731. Mountain View, CA. 2009. Available at: http://www.google.com/earth/download/ge/agree.html. Accessed on March 3, 2014.
26. Royston P. Multiple imputation of missing values. Stata J. 2004;4: 227-241.
27. Rubin DB. Multiple Imputation for Nonresponse in Surveys. Hoboken, New Jersey; John Wiley & Sons; 2004.
28. Royston P, Carlin JB, White IR. Multiple imputation of missing values: new features for mim. Stata J. 2009;9:252.
29. White IR, Royston P. Imputing missing covariate values for the cox model. Stat Med. 2009;28:1982-1998.
30. IeDEA Pediatric Working Group. A survey of paediatric HIV programmatic and clinical management practices in Asia and sub-Saharan Africa-the international epidemiologic databases to evaluate AIDS (IeDEA). J Int AIDS Soc. 2013;16:17998.
31. McNairy ML, Lamb MR, Carter RJ, et al. Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania. J Acquir Immune Defic Syndr. 2013;62:e70-e81.
32. Weigel R, Estill J, Egger M, et al. Mortality and loss to follow-up in the first year of ART: Malawi national ART programme. AIDS. 2012;26: 365-373.
33. Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS. 2008;22:97-105.
34. Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS One. 2014;9:e88166.
35. Nakiwogga-Muwanga A, Musaazi J, Katabira E, et al. Early tracking after a missed return visit reduces the proportion of untraceable patients at a large HIV clinic in Kampala, Uganda. J Int Assoc Provid AIDS Care. 2014. [Epub ahead of print, April 9, 2014].
36. Brinkhof MWG, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009;4:e5790.
37. Fenner L, Brinkhof MWG, Keiser O, et al. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr. 2010;54:524-532.